___

• Düzenli, T., & Demirci, H. Akut Karaciğer Yetmezliği..http://guncel.tgv.org.tr/journal/71/pdf/100540.pdf . Son erişim : Mart 2021
• Mowat AP: Liver transplantation. In Liver Disorders in Childhood, 3rd Ed. Oxford: Butterworth-Heinemann Ltd. 1994, pp 433-52
• EASL Clinical Practical Guidelines on the management of acute (fulminant) liverfailure. JHepatol. 2017 May;66(5):1047-1081.
• BroomeU,BergquistA.:Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis. 2006;26(1):31-41.
• Matsumoto T, Kobayashi S, Shimizu H, Nakajima M, Watanabe S, Kita- mi N, Sato N, Abe H, Aoki Y, Hoshi T, Hashimoto H. The liver in collagen diseases: pathologic study of160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia ofthe liver. Liver 2000: 20: 366–373
• Dolar E.Karaciğer sirozu. Klinik karaciğer hastalıkları. Bursa, Nobel-Güneş tıp kitapevi, 2002,pp.343–361
• Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009;361: p. 1279-90
• Ryckman FC, Bucuvalas JC, Nathan J, Alonso M, Tiao G, Balistreri WF: Outcomes following liver transplantation. Seminars in Pediatric Surgery. 2008;17:123-130
• VaroE,PadinE,OteroE,etal:Cardiovascularrisk factors in liver allograft recipients: relationship with immunosuppressive therapy. Transplantation Proceedings. 2002;34(5):1553-1554.
• Karaciğer Hastalıkları Patolojisi Ek Ders Notları. Yrd.Doç.Dr. Gülbin Şennazlı http://cdn.istanbul.edu.tr/FileHandler2.ashx?f=karaciger-hastaliklarinin-patolojisi.pdf Son erişim : Mart 2021
• Shihab FS. Metabolic complications. In: Norman DJ, Turka LA, editors. Primer on transplantation. 2nd ed. Mt Laurel, NJ: American Society of Transplantation; 2001. p. 247-56.
• Little JW, Falace DA, Miller CS, Rhodus NL. Dental management of the medically compromised patient. 6th ed. St Louis: Mosby, Inc; 2002. p. 501-25.
• Douglas LR, Douglass JB, Sieck JO, Smith PJ. Oral management of the patient with end-stage liver disease and the liver transplant patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:55-64.
• Tyler MT, Lozada-Nur, F, Glick, M, editors. Clinician’s guide to treatment of medically complex dental patients. 2nd ed. Baltimore: The American Academy of Oral Medicine; 2001.
• James Guggenheimer, DDS, a Bijan Eghtesad, MD, b and Debra J. Stock, Dental management of the (solid) organ transplant patientMS, BSN, RN, CCTC, c Pittsburgh, Pa UNIVERSITY OF PITTSBURGH
• Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997;277:1794-801.
• Asikainen, S., and S. Alaluusua. “Bacteriology of dental infections.” European heart journal 14 (1993): 43-50.
• Reynolds-Campbell, Glendee, Alison Nicholson, and Camille-Ann Thoms-Rodriguez. “Oral bacterial infections: diagnosis and management.” Dental Clinics 61.2 (2017): 305-318.
• Robertson,D., andA.J.Smith.“The microbiology of the acute dental abscess.” Journal of medical microbiology 58.2 (2009): 155-162
• Whitington PF, Balistreri WF: Liver transplantation in pediatrics: indications, contraindications, and pretransplant management. J Pediatr 118:169-77, 1991.
• Majewski RF, Hess J, Kabani S, Ramanathan G: Dental find ings in a patient with biliary atresia. J Clin Pediatr Dent 18:32-37, 1993.
• Hosey MT, Gordon G, Kelly DA, Shaw L: Oral findings in children with livertransplants. Int J Paediatr Dent 5:29-34, 1995.
• Morisaki I, Abe K, Tong LSM, Kato K, Sobue S: Dental find ings of children with biliary atresia: report of seven cases. ASDC J Dent Child 57:220-23, 1990.
• Belanger GK, Sanger R, Casamassimo PS, Bystrom EB: Oral and systemic findings in biliary atresia: report of 11 cases. Pediatr Dent 4:322-26, 1982.
• Seow WK, Shepherd RW, Ong TH: Oral changes associated with end-stage liver disease and liver transplantation: implications for dental management. ASDC J Dent Child 58:474- 80, 1991.
• Zaia AA, Graner E, deAlmeida OP, Scully C: Oral changes associated with biliary atresia and liver transplantation. J Clin Pediatr Dent 18:38-42, 1993.
• Kalayoglu M, Stratta RJ, Sollinger HW, Hoffman RM, D’Alessandro AM, Pirsch JD, Belzer FO: Liver transplantation in infants and children. J Pediatr Surg 24:70-76, 1989.
• https://www.researchgate.net/publication/5267241 Son erişim : Mart 2021
• https://onlinelibrary.wiley.com/doi/full/10.1111/idj.12146 Son erişim : Mart 2021
• McEvoy GK, editor. AHFS drug information 2005. Bethesda (MD): American Society of Health-System Pharmacists, American Hospital Formulary Service; 2005.
• Mosby ’s drug consult. 15th edition. St. Louis (MO): Mosby; 2005.
• Lewis GP, Jusko WJ. Pharmacokinetics of ampicillin in cirrhosis. Clin Pharmacol Ther 1975; 18: 475–84.
• Sambatakou, Helen, et al. “Pharmacokinetics of fluoroquinolones in uncompensated cirrhosis: the significance of penetration in the ascitic fluid.” International journal of antimicrobial agents 18.5 (2001): 441-444.
• Vuppalanchi, Raj, et al. “Drug-induced QT prolongation in cirrhotic patients with transjugular intrahepatic portosystemic shunt.” Journal of clinical gastroenterology 45.7 (2011): 638-642.
• Amarapurkar, Deepak N. “Prescribing medications in patients with decompensated liver cirrhosis.” International journal of hepatology 2011 (2011).
• Lewis, J. H., and J. G. Stine. “prescribing medications in patients with cirrhosis–a practical guide.” Alimentary pharmacology & therapeutics 37.12 (2013): 1132-1156.
• Segarra-Newnham, Marisel, and Amy Henneman. “Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in patients without gastrointestinal bleeding.” Annals of Pharmacotherapy 44.12 (2010): 1946-1954.
• Peterson MC. Spontaneous bacterial peritonitis from Streptococcus salivarius in a compromised host. J Infect 2002;45(3):197–8.
• Olyaei AJ, de Mattos AM, Bennett WM. Commonly used drugs and interactions. In: Norman DJ, Turka LA, editors. Primer on transplantation. 2nd ed. Mt Laurel (NJ): American Society of Transplantation; 2001. p. 99-113.
• Golla K, Epstein JB, Cabay RJ. Liver disease: current perspectives on medical and dental management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98:516–21.
• Madden AM, Bradbury W, Morgan MY. Taste perception in cirrhosis:its relationship to circulating micronutrients and food preferences. Hepatology 1997;6:40–8.
• Mandel L, Hamele-Bena D. Alcoholic parotid sialadenosis. J Am Dent Assoc 1997;128: 1411–5.
• https://www.researchgate.net/profile/F_Firriolo/publication/6794913_Dental_Management_of_Patients_with_End-Stage_Liver_Disease/links/5b1ff0c1a6fdcc69745ceaa4/Dental-Management-of-Patients-with-End-Stage-Liver-Disease.pdf Son erişim : Mart 2021
• Glick M. Medical considerations for dental care of patients with alcohol-related liver disease. J Am Dent Assoc 1997;128(8):61–70.
• Howden CW, Birnie GG, Brodie MJ. Drug metabolism in liver disease. Pharmacol Ther 1989;40:439–74.